Literature DB >> 1538237

Is necrosis helpful in the grading of gliomas? Editorial opinion.

E C Alvord1.   

Abstract

The major function of a classification of neoplasms is to correlate with prognosis. During the 1980s two trends developed in the classification of gliomas: 1) the presence of necrosis in astrocytomas defines a subset with the worst prognosis (glioblastoma multiforme) and 2) no comparable subset of oligodendroglioma appears to exist, either histologically or prognostically. Even the worst of the oligodendrogliomas has a better prognosis than glioblastomas. These asymmetries must be kept in mind when one is considering the diagnosis of glioblastoma. The absence of a specific stain for oligodendrogliomas, the difficulty in differentiating small anaplastic cells from oligodendroglial cells and the common occurrence of mixtures of normal and/or reactive oligodendroglia and astrocytes in gliomas combine to create potentially confusing misclassification of many gliomas.

Entities:  

Mesh:

Year:  1992        PMID: 1538237     DOI: 10.1097/00005072-199203000-00002

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  11 in total

1.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

Authors:  M A Hammoud; R Sawaya; W Shi; P F Thall; N E Leeds
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Imaging characteristics of oligodendrogliomas that predict grade.

Authors:  L Khalid; M Carone; N Dumrongpisutikul; J Intrapiromkul; D Bonekamp; P B Barker; D M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

3.  Oligoastrocytomas: a clinicopathological study of 52 cases.

Authors:  H G Krouwer; S G van Duinen; W Kamphorst; P van der Valk; A Algra
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

4.  Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas.

Authors:  Abderrahmane Hamlat; Stephan Saikali; Jacques Chaperon; Beatrice Carsin-Nicol; Michéle Le Calve; Thierry Lesimple; Mohamed Ben-hassel; Yvon Guegan
Journal:  J Neurooncol       Date:  2006-09       Impact factor: 4.130

5.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.

Authors:  C Daumas-Duport; M L Tucker; H Kolles; P Cervera; F Beuvon; P Varlet; N Udo; M Koziak; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

6.  A histopathological contribution to supratentorial glioma grading, definition of mixed gliomas and recognition of low grade glioma with Rosenthal fibers.

Authors:  J M Cillekens; J A Beliën; P van der Valk; T J Faes; P J van Diest; M A Broeckaert; J H Kralendonk; W Kamphorst
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

7.  An acidic environment changes cyclin D1 localization and alters colony forming ability in gliomas.

Authors:  Joachim B Schnier; Kayoko Nishi; William R Harley; Fredric A Gorin
Journal:  J Neurooncol       Date:  2008-04-11       Impact factor: 4.130

Review 8.  Prognostic significance of proteolytic enzymes in human brain tumors.

Authors:  A K Bindal; M Hammoud; W M Shi; S Z Wu; R Sawaya; J S Rao
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma.

Authors:  Karl Bélanger; David MacDonald; Gregory Cairncross; Stan Gertler; Peter Forsyth; Susan Burdette-Radoux; Julie Bergeron; Denis Soulières; Samuel Ludwin; Nancy Wainman; Elizabeth Eisenhauer
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

10.  pERK, pAkt and pBad: a possible role in cell proliferation and sustained cellular survival during tumorigenesis and tumor progression in ENU induced transplacental glioma rat model.

Authors:  Vasanth Kumar Bhaskara; Challa Sundaram; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 4.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.